Diary News and Research

RSS

Antioxidants and pancreatic cancer risk: an interview with Dr Andrew Hart

The antioxidants that we mainly looked at were selenium, vitamin C and vitamin E. They are chemicals which inactivate pro-oxidants or free radicals. Smoking and normal metabolism can lead to the production of free radicals.

30 Jul 2012

Pancreatic cancer risk may be lowered by high dietary antioxidant intake

Increasing dietary intake of the antioxidant vitamins C, E, and selenium could help cut the risk of developing pancreatic cancer by up to two thirds, suggests research published online in the journal Gut.

24 Jul 2012

Redesign of 'outdated and unsafe' medical bags can cut MRSA risk

A new medical bag designed in the UK is set to transform treatment around the world after a study found a third of its outdated predecessors carry the MRSA bug.

21 Jul 2012

Migraine involves multiple symptoms that vary widely among sufferers

Almost everyone suffers from headache pain occasionally, but for 36 million Americans, intense, debilitating headaches accompanied by other neurological symptoms — also known as migraine syndrome — are a source of physical misery that can have a devastating effect on their quality of life. It is estimated that the medical expenses and loss of productivity caused by migraine costs Americans $20 billion annually.

14 Jul 2012

Visual, auditory hallucinations often co-occur in psychosis patients

Visual hallucinations are common in patients with psychosis spectrum disorders and often co-occur with auditory hallucinations, researchers report.

11 Jul 2012

Lesogaberan development halts following disappointing results

Lesogaberan is only marginally superior to placebo in gastroesophageal reflux disease patients who are partially responsive to proton pump inhibitor therapy, results show.

10 Jul 2012

Hay fever symptom severity plateau identified

Study findings suggest that individuals sensitized to Poaceae, a family of land grasses, experience increasing severity in hay fever symptoms in line with daily levels, up to a saturation point.

2 Jul 2012

Ambulatory monitoring will become more and more part of patients' everyday lives

In the future, patients will become even more involved in the observation and monitoring of their own health or illnesses. For example, blood pressure can be checked 24 hours a day using a blood pressure cuff at home.

22 Jun 2012

CINJ commences enrollment in three-drug combination trial for breast cancer

Researchers at The Cancer Institute of New Jersey (CINJ) are enrolling patients for a clinical trial, which aims to evaluate a new drug for breast cancer that has spread (metastatic) in combination with two chemotherapy agents called doxorubicin and cyclophosphamide.

18 Jun 2012

Viewpoints: Bishops' request for contraception exemption may push legal precedent; Maine's experiment on health care

43 Roman Catholic organizations have filed lawsuits challenging a ... regulation that requires employers or their health insurers to offer birth control coverage to workers. The plaintiffs say that complying with the regulation would violate their religious freedom.

1 Jun 2012

Doctors may predict girls at increased risk of eating disorders based on food choices

Doctors may be able to predict which girls are at risk of developing eating disorders based on the food choices they make when they are younger, according to a new study by Cincinnati Children's Hospital Medical Center.

30 May 2012

Mediterranean diet associated with mental and physical health

The study has been published in the 'European Journal of Clinical Nutrition.' For years the Mediterranean diet has been associated with a lesser chance of illness and increased well-being. A new study has now linked it to mental and physical health too.

29 May 2012

Optimi prototype effectively predicts people at risk of depression

The computing tool, developed by researchers at the Universitat Jaume I in Castellón, the Universitat Politècnica of València and the Universitat de València, along with professionals from the company everis, is able to predict if a person with a high-stress level is at risk of becoming depressed, based on the study of a series of physiological and psychological variables in which artificial intelligence techniques are used.

24 May 2012

Health Union introduces Migraine Meter mobile app

Migraine Meter, a free mobile app to help patients manage and monitor their migraines launched today by Health Union, LLC. The app features the latest migraine news, patient tips and expert opinions from Migraine.com and an interactive journal with limitless data storage. It is available for download on iPhone and Android smartphones.

19 May 2012

Dyax introduces free Attack Tracker smartphone application for hereditary angioedema patients

Dyax Corp. today announced the launch of a free smartphone application for the iPhone - HAE Attack Tracker. This application allows HAE patients to keep detailed records of their disease related information, including emergency and physician contacts as well as individual attack data.

11 May 2012

Americans spend only about two hours each week in sports and fitness activities

Americans spend, on average, only about two hours each week participating in sports and fitness activities, according to researchers at Penn State and the University of Maryland who examined U.S. government data from the American Time Use Study.

9 May 2012

Pfizer terminates Lyrica Phase 3 trial on neuropathic pain associated with HIV neuropathy

Pfizer Inc. announced today that it has stopped a Phase 3 clinical trial of Lyrica (pregabalin) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain usually beginning in the feet. The decision follows review of a planned interim analysis of the study by the trial's external Data Monitoring Committee.

5 May 2012

New URMC trial to evaluate carvedilol for high blood pressure

Researchers at the University of Rochester Medical Center are testing whether different doses of an established blood pressure medication can provide the same benefits as a standard dose in people with mild hypertension, possibly with fewer side effects and at a lower cost. The newly launched clinical trial, funded with a $1.9 million grant from the National Heart Lung and Blood Institute, is the first of its kind in the United States.

27 Apr 2012

Positive top-line results from Shire’s Vyvanse Phase 2 study on binge eating disorder

Shire plc, the global specialty biopharmaceutical company, today announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) in adults with binge eating disorder.